The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation
Sign Up to like & getrecommendations! Published in 2017 at "Hereditary Cancer in Clinical Practice"
DOI: 10.1186/s13053-017-0076-7
Abstract: Germline variants within BRCA1 or BRCA2 genes account for approximately 25% of familial aggregations of breast-ovarian cancers. Low or no expression of BRCA1 in breast and ovarian cancers is associated with a good clinical response… read more here.
Keywords: associated brca1; ovarian cancers; breast ovarian; cancers associated ... See more keywords